Free Trial
NASDAQ:PHAR

Pharming Group (PHAR) Stock Price, News & Analysis

Pharming Group logo
$15.13 +0.26 (+1.75%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pharming Group Stock (NASDAQ:PHAR)

Key Stats

Today's Range
$14.42
$15.60
50-Day Range
$9.50
$14.87
52-Week Range
$6.73
$17.08
Volume
21,192 shs
Average Volume
6,544 shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00
Consensus Rating
Buy

Company Overview

Pharming Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

PHAR MarketRank™: 

Pharming Group scored higher than 59% of companies evaluated by MarketBeat, and ranked 460th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pharming Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pharming Group has received no research coverage in the past 90 days.

  • Read more about Pharming Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Pharming Group are expected to grow in the coming year, from ($0.20) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharming Group is -116.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharming Group is -116.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharming Group has a P/B Ratio of 4.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pharming Group's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pharming Group have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharming Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharming Group has recently decreased by 73.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pharming Group does not currently pay a dividend.

  • Dividend Growth

    Pharming Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Pharming Group have been sold short.
  • Short Interest Ratio / Days to Cover

    Pharming Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharming Group has recently decreased by 73.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pharming Group has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Pharming Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for PHAR on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pharming Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharming Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.07% of the stock of Pharming Group is held by insiders.

  • Percentage Held by Institutions

    Only 0.03% of the stock of Pharming Group is held by institutions.

  • Read more about Pharming Group's insider trading history.
Receive PHAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHAR Stock News Headlines

Pharming Group names new finance head
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Pharming Group NV (PHARMA.XD) - Yahoo Finance
Pharming Group N.V. Reports Strong Q2 Earnings
Pharming Group to participate in August investor conference
See More Headlines

PHAR Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $10.06 at the beginning of 2025. Since then, PHAR stock has increased by 50.4% and is now trading at $15.1290.

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) announced its quarterly earnings results on Thursday, July, 31st. The company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.10) by $0.16. The company earned $93.20 million during the quarter, compared to analyst estimates of $70.36 million. Pharming Group had a negative trailing twelve-month return on equity of 3.31% and a negative net margin of 2.19%.
Read the conference call transcript
.

Top institutional investors of Pharming Group include Silverberg Bernstein Capital Management LLC (0.08%) and EverSource Wealth Advisors LLC.

Shares of PHAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharming Group investors own include Pharming Group (PHGUF), Meta Platforms (META), NVIDIA (NVDA), Sunworks (SUNW), Applied DNA Sciences (APDN), AstraZeneca (AZN) and Costco Wholesale (COST).

Company Calendar

Last Earnings
7/31/2025
Today
9/05/2025
Next Earnings (Estimated)
10/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PHAR
CIK
1828316
Fax
N/A
Employees
280
Year Founded
N/A

Price Target and Rating

High Price Target
$39.00
Low Price Target
$14.00
Potential Upside/Downside
+101.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.84 million
Net Margins
-2.19%
Pretax Margin
1.04%
Return on Equity
-3.31%
Return on Assets
-1.78%

Debt

Debt-to-Equity Ratio
0.38
Current Ratio
2.79
Quick Ratio
2.07

Sales & Book Value

Annual Sales
$297.20 million
Price / Sales
3.43
Cash Flow
$0.08 per share
Price / Cash Flow
193.72
Book Value
$3.25 per share
Price / Book
4.58

Miscellaneous

Outstanding Shares
68,510,000
Free Float
67,097,000
Market Cap
$1.02 billion
Optionable
Not Optionable
Beta
0.05

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:PHAR) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners